Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
MK-677: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after MK-677 therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to MK-677 overviewDuring Treatment (4 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| IGF-1 | ↑ increases | Every 8 weeks |
| Fasting Glucose | ↑ increases | Every 4 weeks |
| GH | ↑ increases | Every 4 weeks |
| Prolactin | ↑ increases | Every 8 weeks |